2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses
Not Applicable
Completed
- Conditions
- Contact Lens Wearer
- Interventions
- Device: samfilcon A Lenses with EPG01 Packaging SolutionDevice: B+L Ultra Lenses
- Registration Number
- NCT05126953
- Lead Sponsor
- Bausch & Lomb Incorporated
- Brief Summary
The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Have no active ocular disease or allergic conjunctivitis.
- Not be using any topical ocular medications.
- Be willing and able to follow instructions.
- Have signed a statement of informed consent.
Exclusion Criteria
- Participating in a conflicting study in the opinion of the Investigator.
- Considered by the Investigator to not be a suitable candidate for participation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description samfilcon A Lenses with EPG01 Packaging Solution samfilcon A Lenses with EPG01 Packaging Solution - B+L Ultra Lenses B+L Ultra Lenses -
- Primary Outcome Measures
Name Time Method Normalized logMAR Visual Acuity 2 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bausch and Lomb Site 01
🇺🇸Rochester, New York, United States